Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. (Q46106796)
Jump to navigation
Jump to search
scientific article published on 27 February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. |
scientific article published on 27 February 2009 |
Statements
Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy (English)
Dong Hua
27 February 2009